课题基金 / 基金详情

Peptide Morphing: Rational Design of Separase Inhibitors

Peptide Morphing: Rational Design of Separase Inhibitors
肽变形:分离酶抑制剂的合理设计
批准号:
6747260
负责人:
Webster L Santos
金额:
$4.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2006-04-30

项目摘要

项目成果

Webster L Santos的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):分离酶最近被确定为一种半胱氨酸蛋白酶,可切割内聚蛋白的Scc1亚基,内聚蛋白是一种复杂的蛋白质,在物理上连接姐妹染色单体,并在有丝分裂纺锤体动力学中起重要作用。这一建议将最近描述的肽变形技术应用于合理设计和合成小的非肽分子来结合和抑制分离酶。我们希望这一提议将通过向具有迫切生物学意义的蛋白质靶标提供功能丰富和立体多样化的配体结构来展示肽变形的力量。分离酶的抑制,特别是在活性位点的抑制,应该揭示染色体生物学的关键方面。
英文摘要
DESCRIPTION (provided by applicant): Separase has recently been identified as a cysteine protease that cleaves the Scc1 subunit of cohesin, a complex protein that physically connects sister chromatids and serves important functions in mitotic spindle dynamics. This proposal applies the recently described technique of peptide morphing in the rational design and synthesis of small nonpeptidic molecules to bind and inhibit separase. It is our hope that this proposal will demonstrate the power of peptide morphing by presenting a functionally rich and stereo diversified ligand structure to a protein target of urgent biologic interest and significance. Inhibition of separase, particularly at the active site, should shed light on key aspects of chromosome biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SPNS2 inhibitors as renal fibrosis therapy
  • 批准号:
    10759681
  • 项目类别:
  • 资助金额:
    $30.14万
  • 财政年份:
    2023
  • 负责人:
    Webster L Santos
  • 依托单位:
Therapeutic Mitochondrial Uncouplers
Therapeutic Mitochondrial Uncouplers
Therapeutic Mitochondrial Uncouplers
海外基金